2021 SCMR立场声明:女性心血管疾病的心血管磁共振检查

2021-05-10 美国心血管核磁共振成像协会 J Cardiovasc Magn Reson.2021 May 10;23(1):52.

2021年5月,美国心血管核磁共振成像协会(SCMR)发布了女性心血管疾病的心血管磁共振检查立场声明。本文主要针对女性心血管疾病患者临床应用心血管磁共振检查提供建议。

中文标题:

2021 SCMR立场声明:女性心血管疾病的心血管磁共振检查

英文标题:

Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR)

发布日期:

2021-05-10

简要介绍:

2021年5月,美国心血管核磁共振成像协会(SCMR)发布了女性心血管疾病的心血管磁共振检查立场声明。本文主要针对女性心血管疾病患者临床应用心血管磁共振检查提供建议。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 SCMR立场声明:女性心血管疾病的心血管磁共振检查.pdf)] GetToolGuiderByIdResponse(projectId=1, id=b033b1c0021061e2, title=2021 SCMR立场声明:女性心血管疾病的心血管磁共振检查, enTitle=Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR), guiderFrom=J Cardiovasc Magn Reson.2021 May 10;23(1):52., authorId=0, author=, summary=2021年5月,美国心血管核磁共振成像协会(SCMR)发布了女性心血管疾病的心血管磁共振检查立场声明。本文主要针对女性心血管疾病患者临床应用心血管磁共振检查提供建议。, cover=https://img.medsci.cn/2021525/1621951009680_2020535.jpg, journalId=0, articlesId=null, associationId=147, associationName=美国心血管核磁共振成像协会, associationIntro=美国心血管核磁共振成像协会(SCMR,Society for Cardiovascular Magnetic Resonance)提供相关继续教育、标准指南、最新研究进展等。有官方杂志《心血管核磁共振成像杂志》, copyright=0, guiderPublishedTime=Mon May 10 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年5月,美国心血管核磁共振成像协会(SCMR)发布了女性心血管疾病的心血管磁共振检查立场声明。本文主要针对女性心血管疾病患者临床应用心血管磁共振检查提供建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=2529, tagName=心血管疾病)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2529, guiderKeyword=心血管疾病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2700, appHits=83, showAppHits=0, pcHits=485, showPcHits=2616, likes=0, shares=17, comments=4, approvalStatus=1, publishedTime=Tue May 25 22:37:22 CST 2021, publishedTimeString=2021-05-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue May 25 21:56:55 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Tue Jan 02 09:42:42 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 SCMR立场声明:女性心血管疾病的心血管磁共振检查.pdf)])
2021 SCMR立场声明:女性心血管疾病的心血管磁共振检查.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1188662, encodeId=0e7011886629c, content=值得关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8de6465631, createdName=ms7000000671946062, createdTime=Thu Jan 27 20:25:01 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011955, encodeId=622b101195506, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Fri Aug 27 09:51:18 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973264, encodeId=d4a59e326440, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd925431652, createdName=ms3000001754844654, createdTime=Sun Jun 13 13:53:59 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968549, encodeId=17d896854962, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0b55502773, createdName=多纳9223, createdTime=Wed May 26 08:37:44 CST 2021, time=2021-05-26, status=1, ipAttribution=)]
    2022-01-27 ms7000000671946062

    值得关注

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1188662, encodeId=0e7011886629c, content=值得关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8de6465631, createdName=ms7000000671946062, createdTime=Thu Jan 27 20:25:01 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011955, encodeId=622b101195506, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Fri Aug 27 09:51:18 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973264, encodeId=d4a59e326440, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd925431652, createdName=ms3000001754844654, createdTime=Sun Jun 13 13:53:59 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968549, encodeId=17d896854962, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0b55502773, createdName=多纳9223, createdTime=Wed May 26 08:37:44 CST 2021, time=2021-05-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1188662, encodeId=0e7011886629c, content=值得关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8de6465631, createdName=ms7000000671946062, createdTime=Thu Jan 27 20:25:01 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011955, encodeId=622b101195506, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Fri Aug 27 09:51:18 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973264, encodeId=d4a59e326440, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd925431652, createdName=ms3000001754844654, createdTime=Sun Jun 13 13:53:59 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968549, encodeId=17d896854962, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0b55502773, createdName=多纳9223, createdTime=Wed May 26 08:37:44 CST 2021, time=2021-05-26, status=1, ipAttribution=)]
    2021-06-13 ms3000001754844654

    不错

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1188662, encodeId=0e7011886629c, content=值得关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8de6465631, createdName=ms7000000671946062, createdTime=Thu Jan 27 20:25:01 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011955, encodeId=622b101195506, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Fri Aug 27 09:51:18 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973264, encodeId=d4a59e326440, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd925431652, createdName=ms3000001754844654, createdTime=Sun Jun 13 13:53:59 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968549, encodeId=17d896854962, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0b55502773, createdName=多纳9223, createdTime=Wed May 26 08:37:44 CST 2021, time=2021-05-26, status=1, ipAttribution=)]
    2021-05-26 多纳9223

    好文章

    0

拓展阅读

2014 AHA/ACC/HHS关于加强心血管疾病和共存疾病患者应用临床实践指南的策略

美国心脏协会(AHA,American Heart Association) · 2014-09-11

2014 BC临床指南:心血管疾病的一级预防

英国哥伦比亚临床实践指南中心(BC,Clinical Practice Guidelines and Protocols in British Columbia) · 2014-04-15

2015 AHA/ADA科学声明:成人2型糖尿病患者心血管疾病的预防(更新版)

美国糖尿病学会(ADA,American Diabetes Association) · 2015-08-05

2016 USPSTF建议声明:阿司匹林用于心血管疾病和结直肠癌的一级预防

美国预防医学工作组(USPSTF,U.S. Preventive Services Task Force) · 2016-04-12

2016 AHA/ASA政策声明:姑息治疗与心血管疾病和中风

美国心脏协会(AHA,American Heart Association) · 2016-08-08